1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Syringes and Needles Overview

3 Products under Development

• 3.1 Syringes and Needles - Pipeline Products by Stage of Development
• 3.2 Syringes and Needles - Pipeline Products by Segment
• 3.3 Syringes and Needles - Pipeline Products by Territory
• 3.4 Syringes and Needles - Pipeline Products by Regulatory Path
• 3.5 Syringes and Needles - Pipeline Products by Estimated Approval Date

4 Syringes and Needles - Pipeline Products under Development by Companies

• 4.1 Syringes and Needles Companies - Pipeline Products by Stage of Development
• 4.2 Syringes and Needles - Pipeline Products by Stage of Development

5 Syringes and Needles Companies and Product Overview

• 5.1 Aquabiliti Company Overview
• 5.2 ARTE CORPORATION Company Overview
• 5.3 Baxter International Inc Company Overview
• 5.4 Becton Dickinson and Co Company Overview
• 5.5 Cincinnati Children's Hospital Medical Center Company Overview
• 5.6 C-Major Ltd Company Overview
• 5.7 Daxor Corp Company Overview
• 5.8 Fernando Kerr Design Company Overview
• 5.9 Galderma SA Company Overview
• 5.10 Globe Medical Tech Inc (Inactive) Company Overview
• 5.11 iScience Interventional Inc Company Overview
• 5.12 Johns Hopkins University Company Overview
• 5.13 Medigard Ltd Company Overview
• 5.14 MonuMedical LLC Company Overview
• 5.15 Neuroelectrics Barcelona SLU Company Overview
• 5.16 NuvOx Pharma LLC Company Overview
• 5.17 Olberon Medical Innovation SAS Company Overview
• 5.18 Owen Mumford Ltd Company Overview
• 5.19 Protectus Medical Devices, Inc. Company Overview
• 5.20 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
• 5.21 Rutgers The State University of New Jersey Company Overview
• 5.22 Silmag SA Company Overview
• 5.23 Syrindicare, Inc Company Overview
• 5.24 Telezon Ltd Company Overview
• 5.25 U-Needle BV Company Overview
• 5.26 Unilife Corporation Company Overview
• 5.27 University of California Berkeley Company Overview
• 5.28 University of California Irvine Company Overview
• 5.29 University of Louisville Company Overview
• 5.30 University of Massachusetts Amherst Company Overview
• 5.31 University of South Florida Company Overview
• 5.32 Virginia Commonwealth University Company Overview

6 Syringes and Needles- Recent Developments

7 Appendix

Syringes and Needles - Medical Devices Pipeline Assessment, 2020

Summary

GlobalData's Medical Devices sector report, “Syringes and Needles - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Syringes and Needles pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Syringes and Needles are medical instruments used to inject a drug or extract body fluids.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Syringes and Needles under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Syringes and Needles and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Syringes and Needles under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date